ACMA

Mary Washington Healthcare Experts to Speak at ACMA National Conference on Reducing Hospital Length of Stay

Retrieved on: 
Thursday, April 4, 2024
Conference, Documentation, FHIR, Management, Health, Patient, Mary Washington Hospital, MD, Length of stay, Music City Center, Hearst Communications, Nursing, ACMA, CMO, Central Time, MCG

NASHVILLE, Tenn., April 4, 2024 /PRNewswire-PRWeb/ -- MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, announces its partners and thought leaders from Mary Washington Healthcare will speak at the 2024 ACMA National Conference. The ACMA conference runs from April 19-22, 2024, at the Music City Center in downtown Nashville, Tennessee.

Key Points: 
  • "Mary Washington Healthcare's implementation of MCG Indicia for Admission Documentation technology has enhanced our new care coordination model."
  • This resulted in Mary Washington Healthcare moving from the bottom 10 percent for length of stay to the top 10 percent.
  • Reducing excess days allowed Mary Washington Healthcare to optimize the use of existing resources ultimately decreasing their nursing premium costs.
  • For more information on the 2024 ACMA National Conference in Nashville, Tennessee, visit the conference website here: https://events.acmaweb.org/website/55550/home/

ACMA Launches Pharmaceutical Industry Think Tank Series

Retrieved on: 
Monday, April 1, 2024
MD, ACMA, Accreditation Council, Policy, Health, Accreditation, Medicine

NEW YORK, April 1, 2024 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA) Think Tank will conduct research, analyze complex issues, and provide informed policy recommendations.

Key Points: 
  • NEW YORK, April 1, 2024 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA) Think Tank will conduct research, analyze complex issues, and provide informed policy recommendations.
  • This aligns with the ACMA mission to raise standards in the pharmaceutical industry.
  • Strategic decisions can hurt a pharmaceutical company, especially during drug launch, said Mena Boules, MD, senior pharmaceutical industry executive.
  • "In the dynamic landscape of healthcare, a pharmaceutical industry think tank serves as a beacon of innovation and expertise, fostering collaborative research and thought leadership" said William Soliman PhD, BCMAS, Founder of the ACMA.

ASIAN HALL OF FAME KICKS-OFF ASIAN HERITAGE MONTH

Retrieved on: 
Wednesday, March 27, 2024
Universe, Yoshi, Manna, CAPE, Consulate, Summer, Woman, Miss Universe, Spring, Miss Universe Japan, Trauma, Getty, GOT, ACMA, Project Runway, Wells Fargo, Collection, Film industry

LOS ANGELES, March 27, 2024 /PRNewswire/ -- Asian Hall of Fame hosts Celebrate Asia Festival at Biltmore Los Angeles on Wednesday, May 1. The annual benefit for the Women Founders Fund supports diversity women in tech, entertainment and arts.

Key Points: 
  • LOS ANGELES, March 27, 2024 /PRNewswire/ -- Asian Hall of Fame hosts Celebrate Asia Festival at Biltmore Los Angeles on Wednesday, May 1.
  • Asian Hall of Fame President & CEO and America's Got Talent vocalist Maki Mae performs Phantom of the Opera, Queen of the Night, Time to Say Goodbye, and Lakme duet with Inductee Ren Hanami (SAG-AFTRA).
  • Asian Hall of Fame's signature Charity Boutique features Mother's Day discounts on luxury gifts and mystery boxes containing cultured pearl.
  • Asian Hall of Fame is a leading cultural, educational, and humanitarian charity that transforms public perception of Asian and Indigenous legacy.

Xometry Appoints James Miln as New Chief Financial Officer

Retrieved on: 
Thursday, February 29, 2024
Miln, CGMA, Yahoo!, University of Cambridge, Rallo, XMTR, Growth, Retirement, Advertising, ACMA, Brexit, EBay, IRC

A veteran of big-name tech and consumer brands, Miln brings considerable financial planning, operational and investor relations expertise to Xometry.

Key Points: 
  • A veteran of big-name tech and consumer brands, Miln brings considerable financial planning, operational and investor relations expertise to Xometry.
  • Miln succeeds retiring CFO Jim Rallo, who will remain as an advisor with Xometry through April.
  • Rallo will work closely with Miln and the rest of the leadership team to ensure a smooth transition.
  • “James’ significant experience across marketplaces, search and advertising will help us capitalize on our leadership position in digitizing manufacturing,” said Randy Altschuler, Chief Executive Officer of Xometry.

Digital platform regulators release working papers on algorithms and AI

Retrieved on: 
Tuesday, January 2, 2024
Literature, Policy, Microsoft, ACCC, ACMA, Government, Industry, European, Competition, Technology, AI, OAIC, Media, Child, Algorithm, Shuichi Shigeno, Medical device

23 November 2023

Key Points: 
  • 23 November 2023
    The Digital Platform Regulators Forum (DP-REG) has published working papers on algorithms and the large language models (LLMs) used in generative artificial intelligence (AI) to mark the launch of its website.
  • Each member contributed to the working papers, reflecting DP‑REG’s purpose to promote a streamlined and cohesive approach to the regulation of digital platform technologies in Australia.
  • The papers support DP-REG’s 2023–24 strategic priorities, which include a focus on understanding the impact of algorithms and evaluating the benefits, risks and harms of generative AI.
  • - Working Paper 1: Literature summary – Harms and risks of algorithms considers the harms and risks posed by some commonly used types of algorithms to end-users and society.

ACMA Introduces First Ever Accredited, Professional Certification for Specialty Pharmaceutical Sales Professionals

Retrieved on: 
Tuesday, November 14, 2023
Food, AMCP, Accreditation, DSM-IV codes, Accreditation Council, Inflammation, Professional, FDA, Medical Affairs Bureau, Certification, Cancer, Food and Drug Administration, Drug development, ACMA, Pharmaceutical industry

NEW YORK, Nov. 14, 2023 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA) , a globally recognized leader and the first and only accrediting body for the pharmaceutical industry, today announced the launch of the first accredited, professional certification program for Specialty Pharmaceutical Sales Professionals.

Key Points: 
  • NEW YORK, Nov. 14, 2023 /PRNewswire/ -- The Accreditation Council for Medical Affairs (ACMA) , a globally recognized leader and the first and only accrediting body for the pharmaceutical industry, today announced the launch of the first accredited, professional certification program for Specialty Pharmaceutical Sales Professionals.
  • The Certified Specialty Pharmaceutical Professional or (CSPP™) Program , is the first and only accredited certification for the rapidly growing area of specialty pharmaceutical sales.
  • Specialty pharmaceutical sales cover a variety of conditions including cancer, inflammatory diseases, and neurological disorders.
  • The CSPP certification program signifies ACMA's commitment to equipping specialty pharmaceutical sales professionals with the tools and knowledge they need to thrive in the rapidly growing specialty pharmaceuticals field.

Massivit 10000-G Wins Prestigious ACE Award for Manufacturing Composites Excellence

Retrieved on: 
Monday, November 6, 2023
CableACE Award, ACE, ACMA, AMCA, TASE, CAMX, American Composites Manufacturers Association, Massivit, LOD

LOD, Israel, Nov. 6, 2023 /PRNewswire/ -- Massivit 3D Printing Technologies (TASE: MSVT), a leading provider of industrial 3D printing systems, has won the 2023 annual Award for Composites Excellence (ACE) in the category of Manufacturing: Equipment and Tooling Innovation for the Massivit 10000-G additive manufacturing system. The award was announced at the CAMX 2023 ACE Awards ceremony in Atlanta, hosted by the American Composites Manufacturing Association (AMCA). Selected from among 7 category contestants, the 10000-G is designed to provide automated production of large-scale custom end parts, tooling, and functional prototyping.

Key Points: 
  • LOD, Israel, Nov. 6, 2023 /PRNewswire/ -- Massivit 3D Printing Technologies (TASE: MSVT), a leading provider of industrial 3D printing systems, has won the 2023 annual Award for Composites Excellence (ACE) in the category of Manufacturing: Equipment and Tooling Innovation for the Massivit 10000-G additive manufacturing system .
  • The award was announced at the CAMX 2023 ACE Awards ceremony in Atlanta, hosted by the American Composites Manufacturing Association (AMCA).
  • This latest industry accolade for the 10000-G confirms market recognition of Massivit's 10000 product line as a game changer for composites manufacturing, having already scooped up a string of industry awards including the 2022 IBEX Innovation Award for Boatbuilding and the 2021 ACE Award.
  • The ACE Award win reconfirms the manufacturing industry's strong need for digital transformation.

Massivit to Showcase the 10000-G's Automation for Composites Manufacturing at CAMX 2023 - USA's Largest Composites Expo

Retrieved on: 
Wednesday, October 25, 2023
CableACE Award, ACMA, Interview, RTM, GDP, GA, TASE, LOD, RIM, 3D printing, Massivit, CAMX

LOD, Israel, Oct. 25, 2023 /PRNewswire/ -- Massivit 3D Printing Technologies (TASE: MSVT), a leading provider of industrial 3D printing systems, has announced that the company will present its Massivit 10000-G additive manufacturing system at the CAMX 2023 tradeshow on October 30th - November 2nd. Event attendees will discover how composites manufacturing bottlenecks can be overcome by using Massivit's advanced additive manufacturing technology, already adopted in multiple industries including automotive, marine, and consumer products. 

Key Points: 
  • LOD, Israel, Oct. 25, 2023 /PRNewswire/ -- Massivit 3D Printing Technologies (TASE: MSVT), a leading provider of industrial 3D printing systems, has announced that the company will present its Massivit 10000-G additive manufacturing system at the CAMX 2023 tradeshow on October 30th - November 2nd.
  • Event attendees will discover how composites manufacturing bottlenecks can be overcome by using Massivit's advanced additive manufacturing technology, already adopted in multiple industries including automotive, marine, and consumer products.
  • The 10000-G will be showcased via live demonstrations throughout the CAMX show, as well as a range of printed production parts and molds on display.
  • The Massivit 10000 product line shifts the paradigm for composites manufacturing, enabling high-speed, direct printing and casting of industrial components for a range of composite applications.

Digital platform regulators make joint submission on AI

Retrieved on: 
Tuesday, September 26, 2023
Department, Technology, Australian Communications and Media Authority, Industry, Shuichi Shigeno, Awareness, Safe, Australian Competition & Consumer Commission, Media, PSM, Privacy, Government, Competition, ACMA, Office of the Australian Information Commissioner, OAIC, Artificial intelligence, Australian Competition and Consumer Commission v Baxter Healthcare Pty Ltd, Growth, AI, ACCC, Privacy Commissioner, Australian Information Commissioner, Department of Industry, Science and Resources, Chair, Medical device, Whaling, Furniture, Science

11 September 2023

Key Points: 
  • 11 September 2023
    In a joint submission to the Department of Industry, Science and Resources consultation on the Safe and responsible AI in Australia discussion paper, members of the Digital Platform Regulators Forum (DP-REG) have outlined the opportunities and challenges presented by rapid advances in artificial intelligence (AI).
  • In its submission, DP-REG highlighted the potential impacts of AI in relation to each member’s existing regulatory framework.
  • The submission also flags that coordination between DP-REG members and other arms of government to leverage complementary strengths and expertise will remain crucial to Australia’s response to AI.
  • Through DP-REG, members engage in ongoing collaboration, information sharing and coordination on digital platform regulation.

BenevolentAI: Appointment of Catherine Isted, ACMA, as Chief Financial Officer

Retrieved on: 
Monday, September 11, 2023
Software, Biotechnology, Pharmaceutical, Finance, Health, Artificial Intelligence, Professional Services, Technology, MSD, Morgan Stanley, Katherine, LSE, AIM, Oxford Biomedica, Nomura, ABN, ABN AMRO, Research, ReNeuron, OXB, BAI, ACMA, CDMO, Merck & Co., Partner, Chemistry, Euronext Amsterdam, CFO, Growth, Merck Sharp & Dohme Federal Credit Union, Corporate development, Management

BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in the development of advanced AI that accelerates biopharma discovery, announces the appointment of Catherine Isted, ACMA, who will be joining the Company as Chief Financial Officer (CFO) with immediate effect.

Key Points: 
  • BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in the development of advanced AI that accelerates biopharma discovery, announces the appointment of Catherine Isted, ACMA, who will be joining the Company as Chief Financial Officer (CFO) with immediate effect.
  • Catherine is an experienced strategic finance professional and chartered accountant with over 25 years within the life sciences industry.
  • She was most recently Chief Executive Officer of ReNeuron (AIM: RENE), a UK-based leader in stem cell-derived exosome technologies, having previously been CFO.
  • Joanna Shields, Chief Executive Officer of BenevolentAI, commented: “We are delighted to welcome Catherine to the BenevolentAI Executive Leadership Team.